Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the clinical launch of its Immune Profile Score (IPS) ...

A new study has revealed that gut bacteria may play a key role in aging, and that specific microbes could be targeted to ...

Researchers have discovered a new way to detect per- and polyfluoroalkyl substances (PFAS) in water. This marks an important step forward in creating testing devices that are simpler, more ...

A recent prospective cross-sectional study in Thailand demonstrates that multitarget stool DNA testing is highly sensitive and specific for detecting colorectal cancer (CRC) among Thai individuals.

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...

A prospective cross-section study by BGI Genomics and Siriraj Hospital demonstrates high accuracy of multitarget stool DNA testing for colorectal cancer detection in Thai individuals, offering a ...

There's a new blood test to screen for colorectal cancer, but a new study found it's not as effective as a colonoscopy or ...

As it approaches the one-year anniversary of its efforts to study how DNA can be used to help identify certain health conditions earlier – leading to better outcomes -- St. Luke’s is looking back on ...

I wanted to take a moment to share my experience with Embark's Breed + Health Test and why I think it's something every dog owner will benefit from. I'm ...

Invest in Natera, Inc. and GeneDx Holdings Corp. for potential growth in the booming precision medicine market. Click for ...

Kevin O'Leary, better known as Mr. Wonderful from Shark Tank, knows a thing or two about making bets that pay off — ...